Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.
byBenzinga Newsdesk
November 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts